199 related articles for article (PubMed ID: 24686327)
1. Long term chronic Pseudomonas aeruginosa airway infection in mice.
Facchini M; De Fino I; Riva C; Bragonzi A
J Vis Exp; 2014 Mar; (85):. PubMed ID: 24686327
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
[TBL] [Abstract][Full Text] [Related]
3. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
Stotland PK; Radzioch D; Stevenson MM
Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
[TBL] [Abstract][Full Text] [Related]
4. Assessing Pseudomonas aeruginosa virulence and the host response using murine models of acute and chronic lung infection.
Kukavica-Ibrulj I; Facchini M; Cigana C; Levesque RC; Bragonzi A
Methods Mol Biol; 2014; 1149():757-71. PubMed ID: 24818948
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomics and biological characterization of sequential Pseudomonas aeruginosa isolates from persistent airways infection.
Bianconi I; Jeukens J; Freschi L; Alcalá-Franco B; Facchini M; Boyle B; Molinaro A; Kukavica-Ibrulj I; Tümmler B; Levesque RC; Bragonzi A
BMC Genomics; 2015 Dec; 16():1105. PubMed ID: 26714629
[TBL] [Abstract][Full Text] [Related]
6. Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections.
Cigana C; Lorè NI; Riva C; De Fino I; Spagnuolo L; Sipione B; Rossi G; Nonis A; Cabrini G; Bragonzi A
Sci Rep; 2016 Feb; 6():21465. PubMed ID: 26883959
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus Impacts Pseudomonas aeruginosa Chronic Respiratory Disease in Murine Models.
Cigana C; Bianconi I; Baldan R; De Simone M; Riva C; Sipione B; Rossi G; Cirillo DM; Bragonzi A
J Infect Dis; 2018 Mar; 217(6):933-942. PubMed ID: 29216403
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.
Alcalá-Franco B; Montanari S; Cigana C; Bertoni G; Oliver A; Bragonzi A
J Antimicrob Chemother; 2012 Apr; 67(4):962-9. PubMed ID: 22294647
[TBL] [Abstract][Full Text] [Related]
10. Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection.
Lorè NI; Veraldi N; Riva C; Sipione B; Spagnuolo L; De Fino I; Melessike M; Calzi E; Bragonzi A; Naggi A; Cigana C
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29315274
[TBL] [Abstract][Full Text] [Related]
11. A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection.
Bayes HK; Ritchie N; Irvine S; Evans TJ
Sci Rep; 2016 Nov; 6():35838. PubMed ID: 27804985
[TBL] [Abstract][Full Text] [Related]
12. Murine models of chronic Pseudomonas aeruginosa lung infection.
van Heeckeren AM; Schluchter MD
Lab Anim; 2002 Jul; 36(3):291-312. PubMed ID: 12144741
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts.
Lorè NI; Cigana C; De Fino I; Riva C; Juhas M; Schwager S; Eberl L; Bragonzi A
PLoS One; 2012; 7(4):e35648. PubMed ID: 22558188
[TBL] [Abstract][Full Text] [Related]
14. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
Yu H; Nasr SZ; Deretic V
Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
16. G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease.
McMorran BJ; Palmer JS; Lunn DP; Oceandy D; Costelloe EO; Thomas GR; Hume DA; Wainwright BJ
Am J Physiol Lung Cell Mol Physiol; 2001 Sep; 281(3):L740-7. PubMed ID: 11504703
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
[TBL] [Abstract][Full Text] [Related]
18. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
Gomi R; Sharma A; Wu W; Sung B; Worgall S
Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
[TBL] [Abstract][Full Text] [Related]
19. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
Yu H; Hanes M; Chrisp CE; Boucher JC; Deretic V
Infect Immun; 1998 Jan; 66(1):280-8. PubMed ID: 9423869
[TBL] [Abstract][Full Text] [Related]
20.
Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
